http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30522219

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 84348
issn 1949-2553
issueIdentifier 48
pageRange 84338-84348
publicationName Oncotarget
startingPage 84338
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_d62f51386142d8e7576b9b70134d6e59
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f864e18cac6d5f6fb15bbca5c16b1a66
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f4d76fcb3ebbd108cdf706a96ff98e1c
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_40db15575911b5e0d518e0fa161ae47c
bibliographicCitation Geybels MS, Fang M, Wright JL, Qu X, Bibikova M, Klotzle B, Fan J, Feng Z, Ostrander EA, Nelson PS, Stanford JL. PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles. Oncotarget. 2017 Sep 15;8(48):84338–48. doi: 10.18632/oncotarget.20940.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c76b8f56a3c9db49e380e9562e95da54
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e24d6495771c43a1fbb42c851b9df02
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_faa7fe064e973c73388d88a0931328ee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b98e78d83378f5a3419ececebbf801e6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9406d7da8f29046aeadd9fd55aebf0ac
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32dd8ec37ac5341c4bfd2f256a47388a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fe6b040f23a51668c10ceb66e82468f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d08bf03834d16555394b5f04e90c569f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd00efdd94594c28d6b813f0e8b0e3e5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5743039dd8f0d49545aa44d71d8840d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4de465618df6ccac9123182eb4947ed9
date 2017-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC5663600
https://pubmed.ncbi.nlm.nih.gov/29137428
https://doi.org/10.18632/oncotarget.20940
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803
https://portal.issn.org/resource/ISSN/1949-2553
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title PTEN loss is associated with prostate cancer recurrence and alterations in tumor DNA methylation profiles
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75a4cc3cc895587989f19a1fc9b9f70c
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_335366b86eab13ea9f6925279dca28aa
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3f8d3401bda0c608a0bababef7fdf856
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8983
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_501529bab78438ef977b38a0b77a3281
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_820ce54606aa6453b670655ff9cca435

Total number of triples: 42.